Vyfat 120 mg Intas Pharmaceuticals

£57.00

Vyfat 120 mg is an orlistat-based lipase inhibitor formulated by Intas Pharmaceuticals for laboratory research investigations of fat absorption mechanisms in controlled settings.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Vyfat 120 mg Intas Pharmaceuticals
Vyfat 120 mg Intas Pharmaceuticals
£57.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

About Vyfat

Vyfat 120 mg is an orlistat-based lipase inhibitor developed by Intas Pharmaceuticals specifically for in-vitro laboratory research applications. This compound belongs to the class of pancreatic lipase inhibitors and contains 120 mg of orlistat as the active research ingredient. Researchers investigating fat absorption mechanisms, lipid metabolism pathways, and digestive enzyme inhibition frequently utilise this compound in controlled laboratory environments. The formulation represents a standardised research tool for examining lipase enzyme interactions and fatty acid processing in experimental models.

As a premier UK research chemical supplier, Stroid UK Shop maintains comprehensive inventory of metabolic research compounds alongside our extensive SARMs collection and peptides catalogue. Laboratory researchers studying lipid metabolism mechanisms can examine Vyfat 120 mg alongside other compounds available in our fat burner research category for comprehensive metabolic investigations.

Laboratory Applications

Research scientists examine Vyfat 120 mg in studies investigating pancreatic lipase enzyme inhibition and its effects on dietary fat absorption in experimental models. The compound demonstrates selective inhibition of gastric and pancreatic lipases, preventing the hydrolysis of dietary triglycerides into absorbable fatty acids and glycerol. Researchers utilise this mechanism to study fat malabsorption pathways, investigate metabolic syndrome models, and examine the relationship between lipase inhibition and energy metabolism regulation.

Laboratory applications include examining dose-response relationships in enzyme inhibition studies, investigating the compound’s effects on lipid metabolism in cell culture systems, and analysing fat absorption kinetics in controlled experimental conditions. Research teams studying obesity mechanisms, metabolic dysfunction, and digestive enzyme physiology frequently incorporate this compound into their experimental protocols for comprehensive metabolic research investigations.

Product Specifications

Vyfat 120 mg Research Specifications
Parameter Specification
Active Ingredient Orlistat 120 mg
Manufacturer Intas Pharmaceuticals
Form Capsules
CAS Number 96829-58-2
Molecular Formula C₂₉H₅₃NO₅
Molecular Weight 495.73 g/mol
Storage Room temperature, dry conditions
Purity Verify with supplier documentation

Research Compliance

Vyfat 120 mg orlistat capsules are supplied exclusively for in-vitro laboratory research purposes and are not intended for human consumption, therapeutic use, or any clinical applications. Research institutions and qualified laboratories must ensure appropriate handling protocols, safety measures, and regulatory compliance when conducting studies with this compound. All investigations should be performed under proper laboratory supervision with appropriate analytical methods for compound verification and experimental validation.

Related